Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Frank G. Holz »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Frank G. Haluska < Frank G. Holz < Frank Geller  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000E45 (2013) Frank G. Holz [Allemagne] ; Francesco Bandello [Italie] ; Mark Gillies [Australie] ; Paul Mitchell [Australie] ; Aaron Osborne [Suisse] ; Tom Sheidow [Canada] ; Eric Souied [France] ; Marta S. Figueroa [Espagne] ; Francesco Bandello ; Christopher Brand ; Mark Gillies ; Frank G. Holz ; Adrian Koh ; Paul Mitchell ; Aaron Osborne ; Ursula Schmidt-Erfurth ; N. Sharma ; Tom Sheidow ; Eric Souied ; Marta S. Figueroa ; Steve WinyardSafety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

List of associated KwdEn.i

Nombre de
documents
Descripteur
1Acuity
1Adverse events
1Advisory boards
1Allergan
1Annual incidence
1Baseline
1Bayer
1Belgium
1Bevacizumab
1Cerebral haemorrhage
1Cerebral infarction
1Cerebrovascular accident
1Clinical practice
1Clinical trials
1Company boards
1Degeneration
1Etdrs letters
1Growth factor
1Haemorrhage
1Health economics
1Helios
1Helios belgium
1Holz
1Honorarium support
1Incidence rates
1Injection procedure
1Interim analysis
1Intracranial haemorrhage
1Intraocular
1Intraocular pressure
1Intravitreal
1Intravitreal bevacizumab
1Intravitreal injection
1Intravitreal ranibizumab
1Lucentis
1Luminous programme
1Macular
1Macular degeneration
1Neovascular
1Neovascular macular degeneration
1Novartis
1Novartis pharma
1Observational settings
1Observational studies
1Ocular
1Ocular events
1Online
1Ophthalmol
1Ophthalmology
1Particular interest
1Polypoidal choroidal vasculopathy
1Preferred terms
1Programme
1Ranibizumab
1Ranibizumab treatment
1Registry
1Research support
1Retrospective
1Safety analysis
1Safety assessment
1Safety events
1Swedish registries
1Travel support
1Vegf
1Vegf inhibition
1Vein occlusion
1Visual acuity

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Frank G. Holz" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Frank G. Holz" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Frank G. Holz
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024